Haleos Labs Ltd. · NSE:HALEOSLABS
Haleos Labs — SMS Lifesciences India — Q3 FY2025 Earnings Presentation
14 slides from Haleos Labs's earnings presentation, Feb 12, 2025
Slide 1: General information about company (Standalone)
Standalone General information about company Scrip code 540679 NSE Symbol SMSLIFE MSEI Symbol NOTLISTED ISIN* INE320X01016 SMS Lifesciences India Name of company Limited Type of company Class of security Equity Date of start of financial year 01-04-2024 Date of end of financial year 31-03-2025 Date
Slide 2: Financial Results – Ind-AS
Financial Results – Ind-AS 3 months/ 6 months ended Year to date figures for current period Particulars (dd-mm-yyyy) ended (dd-mm-yyyy) A Date of start of reporting period 01-10-2024 01-04-2024 B Date of end of reporting period 31-12-2024 31-12-2024 C Whether results are audited or unaudited Unaudit
Slide 3: Financial Results – Ind-AS
Financial Results – Ind-AS 3 months/ 6 months ended Year to date figures for current Particulars (dd-mm-yyyy) period ended (dd-mm-yyyy) A Date of start of reporting period 01-10-2024 01-04-2024 B Date of end of reporting period 31-12-2024 31-12-2024 C Whether results are audited or unaudited Unaudit
Slide 4: Financial Results – Ind-AS
Financial Results – Ind-AS 3 months/ 6 month ended (dd- Year to date figures for current period Particulars mm-yyyy) ended (dd-mm-yyyy) A Date of start of reporting period 01-10-2024 01-04-2024 B Date of end of reporting period 31-12-2024 31-12-2024 C Whether results are audited or unaudited Unaudit
Slide 5: Financial Results – Ind-AS
Financial Results – Ind-AS 3 months/ 6 months ended Year to date figures for current period Particulars (dd-mm-yyyy) ended (dd-mm-yyyy) A Date of start of reporting period 01-10-2024 01-04-2024 B Date of end of reporting period 31-12-2024 31-12-2024 C Whether results are audited or unaudited Unaudit
Slide 6: Text Block
Text Block 1. The above standalone Financial Results have been reviewed and recomended by the Audit Committee on 12th February, 2025 and have been approved by the Board of Directors at its meeting held on 12th February, 2025.The statutory auditors of the Company have carried out limited review of St
Slide 7: Format for Reporting Segment wise Revenue, Results and Capital Employed
Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results 3 months/ 6 month ended (dd- Year to date figures for current period ended Particulars mm-yyyy) (dd-mm-yyyy) Date of start of reporting period 01-10-2024 01-04-2024 Date of end of reporting period
Slide 8: General information about company (Consolidated)
General information about company Consolidated Scrip code 540679 NSE Symbol SMSLIFE MSEI Symbol NOTLISTED ISIN* INE320X01016 SMS Lifesciences India Name of company Limited Type of company Class of security Equity Date of start of financial year 01-04-2024 Date of end of financial year 31-03-2025 Dat
Slide 9: Financial Results – Ind-AS
Financial Results – Ind-AS 3 months/ 6 months ended (dd- Year to date figures for current period Particulars mm-yyyy) ended (dd-mm-yyyy) A Date of start of reporting period 01-10-2024 01-04-2024 B Date of end of reporting period 31-12-2024 31-12-2024 C Whether results are audited or unaudited Unaudi
Slide 10: Financial Results – Ind-AS
Financial Results – Ind-AS 3 months/ 6 months ended Year to date figures for current Particulars (dd-mm-yyyy) period ended (dd-mm-yyyy) A Date of start of reporting period 01-10-2024 01-04-2024 B Date of end of reporting period 31-12-2024 31-12-2024 C Whether results are audited or unaudited Unaudit
Slide 11: Financial Results – Ind-AS
Financial Results – Ind-AS 3 months/ 6 month ended (dd- Year to date figures for current period ended Particulars mm-yyyy) (dd-mm-yyyy) A Date of start of reporting period 01-10-2024 01-04-2024 B Date of end of reporting period 31-12-2024 31-12-2024 C Whether results are audited or unaudited Unaudit
Slide 12: Financial Results – Ind-AS
Financial Results – Ind-AS 3 months/ 6 months ended Year to date figures for current period Particulars (dd-mm-yyyy) ended (dd-mm-yyyy) A Date of start of reporting period 01-10-2024 01-04-2024 B Date of end of reporting period 31-12-2024 31-12-2024 C Whether results are audited or unaudited Unaudit
Slide 13: Text Block
Text Block 1. The above Consolidated Financial Results have been reviewed and recomended by the Audit Committee on 12th February, 2025 and have been approved by the Board of Directors at its meeting held on 12th February, 2025.The statutory auditors of the Company have carriedout the limited review
Slide 14: Format for Reporting Segment wise Revenue, Results and Capital Employed
Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results 3 months/ 6 month ended (dd- Year to date figures for current period ended Particulars mm-yyyy) (dd-mm-yyyy) Date of start of reporting period 01-10-2024 01-04-2024 Date of end of reporting period
SMS Lifesciences India — Q3 FY2025 Earnings Presentation on 6ix